Stocks and Investing Stocks and Investing
Tue, November 24, 2020

Matthew Harrison Initiated (AVIR) at Buy and Held Target at $49 on, Nov 24th, 2020


Published on 2024-10-27 14:51:41 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Initiated "Atea Pharmaceuticals, Inc." (AVIR) at Buy and Held Target at $49 on, Nov 24th, 2020.

Matthew, nor any peers, have made any analyst calls on AVIR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources